Literature DB >> 2537253

Evaluation of the mouse model for study of encephalopathy in pertussis vaccine recipients.

E L Hewlett1, J L Cowell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2537253      PMCID： PMC313157          DOI： 10.1128/iai.57.3.661-663.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  21 in total

1.  Neurological complications of pertussis immunization.

Authors:  J M BERG
Journal:  Br Med J       Date:  1958-07-05

Review 2.  Neurotoxicity of Bordetella pertussis.

Authors:  M Pittman
Journal:  Neurotoxicology       Date:  1986       Impact factor: 4.294

3.  Neurological complications of pertussis inoculation.

Authors:  M Kulenkampff; J S Schwartzman; J Wilson
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

4.  Benefit versus risk factors in cholera and typhoid immunization.

Authors:  I Joó
Journal:  Dev Biol Stand       Date:  1979

5.  Murine responses to immunization with pertussis toxin and bovine serum albumin: I. Mortality observed after bovine albumin challenge is due to an anaphylactic reaction.

Authors:  S E Wiedmeier; H T Chung; B H Cho; U H Kim; R A Daynes
Journal:  Pediatr Res       Date:  1987-09       Impact factor: 3.756

6.  Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin).

Authors:  J J Munoz; M G Peacock; W J Hadlow
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

7.  The activity of purified Bordetella pertussis components in murine encephalopathy.

Authors:  K Redhead; A Robinson; L A Ashworth; M Melville-Smith
Journal:  J Biol Stand       Date:  1987-10

8.  Is the acute encephalopathy test in mice suited for control of pertussis vaccines?

Authors:  M Au-Jensen; I Heron
Journal:  Dev Biol Stand       Date:  1985

9.  Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children.

Authors:  D Miller; J Wadsworth; J Diamond; E Ross
Journal:  Dev Biol Stand       Date:  1985

10.  Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.

Authors:  L Steinman; A Weiss; N Adelman; M Lim; J Oehlert; R Zuniga; E Hewlett; S Falkow
Journal:  Dev Biol Stand       Date:  1985
View more
  4 in total

1.  Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.

Authors:  M A Schmidt; B Raupach; M Szulczynski; J Marzillier
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.

Authors:  M A Schmidt; W Schmidt
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.

Authors:  A Kimura; K T Mountzouros; P A Schad; W Cieplak; J L Cowell
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components.

Authors:  J Blood-Siegfried; E Crabb Breen; S Takeshita; O Martinez-Maza; D Vredevoe
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.